Revolution Medicines, Inc. RVMD
Revenue Intelligence Report • 19 quarters of SEC filing data • Updated 2026-10-14 • Data through 2023-12-31
Revolution Medicines, Inc. has SEC quarterly revenue data through 2023-12-31. Latest available quarterly SEC revenue ends 2023-12-31; a current forecast is withheld.
Annualized Revenue
$2.97M
SEC Filings
19 quarters
Profile-only page: Latest available quarterly SEC revenue ends 2023-12-31; a current forecast is withheld.
Quarterly Revenue History
| Quarter Ending | Revenue |
|---|---|
| 2019-03-31 | $13.2M |
| 2019-06-30 | $12.3M |
| 2019-09-30 | $12.5M |
| 2019-12-31 | $12.1M |
| 2020-03-31 | $11.5M |
| 2020-06-30 | $10.0M |
| 2020-09-30 | $12.7M |
| 2020-12-31 | $8.8M |
| 2021-03-31 | $10.1M |
| 2021-06-30 | $8.7M |
| 2021-09-30 | $1.1M |
| 2021-12-31 | $9.5M |
| 2022-03-31 | $7.6M |
| 2022-06-30 | $9.1M |
| 2022-09-30 | $3.4M |
| 2022-12-31 | $15.3M |
| 2023-03-31 | $7.0M |
| 2023-06-30 | $3.8M |
| 2023-12-31 | $0.7M |
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch